Skip to main content

Table 2 Recurrent tumor distribution (n = 51)

From: 18F-FDG PET/CT-based metabolic metrics in recurrent tumors of ovarian clear cell carcinoma and their prognostic implications

  Numbers (%)
Pelvis
 Pelvic tumor 7 (13.7%)
 Vaginal cuff tumor 6 (11.8%)
 Pelvic peritoneum 1 (2.0%)
 Rectal tumor 1 (2.0%)
Peritoneal carcinomatosis 8 (15.7%)
Lymph node metastases
 Multiple lymph nodes 7 (13.7%)
 Peri-aortic lymph node 1 (2.0%)
 Retro-pancreatic lymph node 1 (2.0%)
Supra-diaphragmatic lymph node 1 (2.0%)
Lung metastasis 2 (3.9%)
Spleen metastasis 1 (2.0%)
Liver metastasis 2 (3.9%)
Hepatorenal recess tumor 3 (5.9%)
Left-side diaphragmatic tumor 1 (2.0%)
Mesocolic tumor and paracolic tumor 3 (5.9%)
Abdominal wall tumor 4 (7.8%)
Intestinal mesentery 2 (3.9%)